Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recombinant alpha-interferons, thyroid irradiation and thyroid disease.

F J Giles1, C P Worman, A P Jewell

  • 1Department of Haematology, University College Hospital, London, UK.

Acta Haematologica
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial.

Bone marrow transplantation·2021
Same author

The evolving role of chemotherapy and hematopoietic cell transplants in Ph-positive acute lymphoblastic leukemia in adults.

Bone marrow transplantation·2017
Same author

Developmental therapeutics for patients with breast cancer and central nervous system metastasis: current landscape and future perspectives.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes.

Blood cancer journal·2017
Same author

Autologous Bone-Marrow Transplantation in Acute Lymphoblastic Leukaemia: 1980-89.

Leukemia & lymphoma·2016
Same author

Systemic Irradiation Therapy of Myelomatosis-The Therapeutic Implications of Technique.

Leukemia & lymphoma·2016

Long-term recombinant alpha-interferon therapy can cause side effects like weight loss and fatigue. It is crucial to differentiate anorexia and depression syndrome from thyroid disease in patients undergoing this treatment.

Area of Science:

  • Immunology
  • Oncology
  • Endocrinology

Background:

  • Recombinant alpha-interferons (IFN-α) are utilized for treating various benign and malignant conditions.
  • Long-term maintenance therapy with IFN-α can lead to patient intolerance due to adverse effects.

Observation:

  • Reported side effects include weight loss, alopecia, chronic fatigue, and anorexia and depression syndrome.
  • This syndrome presents symptoms that may be confused with endocrine disorders.

Findings:

  • The study documents cases where patients on recombinant alpha-interferon therapy developed thyroid disease.
  • Anorexia and depression syndrome associated with IFN-α therapy requires careful distinction from actual thyroid dysfunction.

Implications:

Related Experiment Videos

  • Accurate diagnosis is essential to manage side effects effectively and ensure continued therapeutic benefit.
  • Distinguishing between drug-induced syndromes and underlying medical conditions like thyroid disease is critical for patient care.